Garrett Keim1, R Scott Watson2, Neal J Thomas3, Nadir Yehya1. 1. Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA. 2. Department of Pediatrics, University of Washington, Seattle, WA. 3. Department of Pediatrics, Penn State University College of Medicine, Hershey, PA.
Abstract
OBJECTIVES: Much of the research related to pediatric acute respiratory distress syndrome has focused on inhospital mortality and interventions affecting this outcome. Limited data exist on survivors' morbidity, hospital disposition, and 1-year survival. The aim of this study was to determine new morbidity rate, discharge disposition, and 1-year mortality for survivors of pediatric acute respiratory distress syndrome. DESIGN: Secondary analysis of prospective cohort study. SETTING: Quaternary children's hospital. PATIENTS: Three-hundred sixteen mechanically ventilated children with pediatric acute respiratory distress syndrome (Berlin and Pediatric Acute Lung Injury Consensus Conference criteria) between July 2011 and December 2014. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We performed secondary analysis of a prospectively recruited cohort of 316 mechanically ventilated children with pediatric acute respiratory distress syndrome between July 2011, and December 2014. Preillness and hospital discharge Functional Status Scale score were determined via chart review, and factors associated with new morbidity, defined as an increase of Functional Status Scale score of 3 or more, were analyzed. Demographic variables, pediatric acute respiratory distress syndrome characteristics, and ventilator management were tested for association with development of new morbidity, discharge disposition, and 1-year mortality. Inhospital mortality of pediatric acute respiratory distress syndrome was 13.3% (42/316). Of 274 survivors to hospital discharge, new morbidity was seen in 63 patients (23%). Discharge to rehabilitation rate was 24.5% (67/274) and associated with development of new morbidity. One- and 3-year mortality of survivors was 5.5% (15 deaths) and 8% (22 deaths) and was associated with baseline Functional Status Scale, immunocompromised status, Pediatric Risk of Mortality III, and organ failures at pediatric acute respiratory distress syndrome onset, but not with pediatric acute respiratory distress syndrome severity. CONCLUSIONS: New morbidity was common after pediatric acute respiratory distress syndrome and appears to be intermediate phenotype between survival without morbidity and death, making it a useful metric in future interventional and outcome studies in pediatric acute respiratory distress syndrome.
OBJECTIVES: Much of the research related to pediatric acute respiratory distress syndrome has focused on inhospital mortality and interventions affecting this outcome. Limited data exist on survivors' morbidity, hospital disposition, and 1-year survival. The aim of this study was to determine new morbidity rate, discharge disposition, and 1-year mortality for survivors of pediatric acute respiratory distress syndrome. DESIGN: Secondary analysis of prospective cohort study. SETTING: Quaternary children's hospital. PATIENTS: Three-hundred sixteen mechanically ventilated children with pediatric acute respiratory distress syndrome (Berlin and Pediatric Acute Lung Injury Consensus Conference criteria) between July 2011 and December 2014. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We performed secondary analysis of a prospectively recruited cohort of 316 mechanically ventilated children with pediatric acute respiratory distress syndrome between July 2011, and December 2014. Preillness and hospital discharge Functional Status Scale score were determined via chart review, and factors associated with new morbidity, defined as an increase of Functional Status Scale score of 3 or more, were analyzed. Demographic variables, pediatric acute respiratory distress syndrome characteristics, and ventilator management were tested for association with development of new morbidity, discharge disposition, and 1-year mortality. Inhospital mortality of pediatric acute respiratory distress syndrome was 13.3% (42/316). Of 274 survivors to hospital discharge, new morbidity was seen in 63 patients (23%). Discharge to rehabilitation rate was 24.5% (67/274) and associated with development of new morbidity. One- and 3-year mortality of survivors was 5.5% (15 deaths) and 8% (22 deaths) and was associated with baseline Functional Status Scale, immunocompromised status, Pediatric Risk of Mortality III, and organ failures at pediatric acute respiratory distress syndrome onset, but not with pediatric acute respiratory distress syndrome severity. CONCLUSIONS: New morbidity was common after pediatric acute respiratory distress syndrome and appears to be intermediate phenotype between survival without morbidity and death, making it a useful metric in future interventional and outcome studies in pediatric acute respiratory distress syndrome.
Authors: Angela M Cheung; Catherine M Tansey; George Tomlinson; Natalia Diaz-Granados; Andrea Matté; Aiala Barr; Sangeeta Mehta; C David Mazer; Cameron B Guest; Thomas E Stewart; Fatma Al-Saidi; Andrew B Cooper; Deborah Cook; Arthur S Slutsky; Margaret S Herridge Journal: Am J Respir Crit Care Med Date: 2006-06-08 Impact factor: 21.405
Authors: Yolanda López-Fernández; Amelia Martínez-de Azagra; Pedro de la Oliva; Vicent Modesto; Juan I Sánchez; Julio Parrilla; María José Arroyo; Susana Beatriz Reyes; Martí Pons-Ódena; Jesús López-Herce; Rosa Lidia Fernández; Robert M Kacmarek; Jesús Villar Journal: Crit Care Med Date: 2012-12 Impact factor: 7.598
Authors: Nadir Yehya; Sabah Servaes; Neal J Thomas; Vinay M Nadkarni; Vijay Srinivasan Journal: Intensive Care Med Date: 2015-07-10 Impact factor: 17.440
Authors: Simon Erickson; Andreas Schibler; Andrew Numa; Gabrielle Nuthall; Michael Yung; Elaine Pascoe; Barry Wilkins Journal: Pediatr Crit Care Med Date: 2007-07 Impact factor: 3.624
Authors: Elizabeth Y Killien; Roel L N Huijsmans; Iesha L Ticknor; Lincoln S Smith; Monica S Vavilala; Frederick P Rivara; R Scott Watson Journal: Crit Care Med Date: 2020-01 Impact factor: 7.598
Authors: Michael C McCrory; Alan G Woodruff; Amit K Saha; Joni K Evans; Elizabeth E Halvorson; Andora L Bass Journal: Pediatr Pulmonol Date: 2022-07-14
Authors: Aline B Maddux; Peter M Mourani; Russell Banks; Ron W Reeder; Murray M Pollack; Robert A Berg; Kathleen L Meert; Patrick S McQuillen; Andrew R Yates; Daniel A Notterman; John T Berger Journal: Respir Care Date: 2021-10 Impact factor: 2.339
Authors: Michelle Vo; Kristen Miller; Tellen D Bennett; Peter M Mourani; Jaime LaVelle; Todd C Carpenter; R Scott Watson; Laura L Pyle; Aline B Maddux Journal: Pediatr Pulmonol Date: 2022-04-26
Authors: Erin F Carlton; Heidi M Weeks; Mary K Dahmer; Michael W Quasney; Anil Sapru; Martha A Q Curley; Heidi R Flori Journal: Crit Care Explor Date: 2021-07-13
Authors: Garrett Keim; Nadir Yehya; Debbie Spear; Mark W Hall; Laura L Loftis; Jeffrey A Alten; Jennifer McArthur; Pallavi P Patwari; Robert J Freishtat; Douglas F Willson; John P Straumanis; Neal J Thomas Journal: Crit Care Med Date: 2020-08 Impact factor: 9.296
Authors: Daniël Bossen; Rosa M de Boer; Hendrika Knoester; Jolanda M Maaskant; Marike van der Schaaf; Mattijs W Alsem; Reinoud J B J Gemke; Job B M van Woensel; Jaap Oosterlaan; Raoul H H Engelbert Journal: Crit Care Explor Date: 2021-06-15